Vermunicht SRL
Vermunicht reported total assets of 602,591 € at the end of the 2024 financial year (annual accounts filed with the NBB on 03 Nov 2025).
The score of Vermunicht shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2024
Change 2021 → 2024: Equity +32 % Total assets +28 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Vermunicht's annual accounts
| 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|
| Net result | 69,679 € | ||||
| Equity | 454,688 € | ||||
| Cash | 284,889 € | ||||
| EBITDA | 107,416 € | ||||
| Total assets | 602,591 € |
Filed annual accounts
- Year ended 31 Dec 2024filed on 03 Nov 2025
- Year ended 31 Dec 2023filed on 03 Nov 2025
- Year ended 31 Dec 2022filed on 21 Sep 2023
- Year ended 31 Dec 2021filed on 14 Oct 2022
- Year ended 31 Dec 2020filed on 31 Aug 2021
Vermunicht's financial analysis
- Solvency75.5%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Vermunicht
Vermunicht's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0841.893.187
- VAT number
- BE0841893187
- Peppol
- Registered · 0208:0841893187 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 14 Dec 2011
- Registered office
- 2235 Hulshout
- Latest accounts
- 2024 · filed on 03 Nov 2025
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Vermunicht (SRL) has been based in Hulshout since 2011, active in: retail sale of pharmaceutical products. For 2024, it reports a net profit of 69,679 € and equity of 454,688 €; its revenue is not published. Its solvency stands at 75.5%, above the median of its sector (44.2%).
Companies similar to Vermunicht
Companies in the same business, of comparable size and area, outside its group.
- Apotheek Roekaerts - DE Schrijver Retail sale of pharmaceutical products Beringen · balance sheet 602,414 €
- Pharmacie DE LA Jonction Retail sale of pharmaceutical products Saint-Josse-ten-Noode · balance sheet 601,403 €
- Smith Pharma Retail sale of pharmaceutical products Willebroek · balance sheet 610,521 €
- "Farminco" Retail sale of pharmaceutical products Andenne · balance sheet 589,804 €
- Geassocieerde Apotheek Merksem Retail sale of pharmaceutical products Antwerp · balance sheet 623,918 €
- Pharmenform Retail sale of pharmaceutical products Koekelberg · balance sheet 567,837 €
- Farma Booischot Retail sale of pharmaceutical products Heist-op-den-Berg · balance sheet 558,918 €
- Kapelfarma Retail sale of pharmaceutical products Kontich · balance sheet 653,987 €
Frequently asked questions about Vermunicht
What is the revenue of Vermunicht?
Vermunicht files its accounts in a format where revenue is optional: it is not published for 2024.
What is the VAT number of Vermunicht?
In Belgium, the VAT number is the company number prefixed with BE: BE0841893187 for Vermunicht, if the company is VAT-registered. Its company number (CBE) is 0841.893.187.
Where is the registered office of Vermunicht?
According to the CBE register, the registered office of Vermunicht is in 2235 Hulshout.
What is the equity of Vermunicht?
At the close of the 2024 financial year, the equity of Vermunicht amounts to 454,688 €, a solvency of 75.5% of total assets.
Who manages Vermunicht?
The register lists 1 active mandates at Vermunicht. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Vermunicht
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →